Glenmark Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE935A01035
  • NSEID: GLENMARK
  • BSEID: 532296
INR
2,648.00
27 (1.03%)
BSENSE

Nov 20

BSE+NSE Vol: 5.53 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGlenmark Pharma VS Pharmaceuticals & Biotechnology
 
1D
1.03%
1.08%
1W
0.19%
2.85%
1M
19.88%
13.63%
YTD
30.07%
-1.53%
1Y
40.73%
-2%
3Y
237.2%
27.82%
5Y
448.35%
40.72%
10Y
194.73%
220.91%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.1%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
13.89%
0.10%
13.99%
6 Months
11.37%
0.11%
11.48%
1 Year
40.73%
0.13%
40.86%
2 Years
77.44%
0.48%
77.92%
3 Years
237.2%
1.22%
238.42%
4 Years
545.85%
2.94%
548.79%
5 Years
448.35%
3.11%
451.46%

Latest dividend: 2.5 per share ex-dividend date: Aug-31-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Industry stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Market Cap stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available